We are proud to announce the birth of the new Pharma Division of GEA: GEA Pharma Systems. We believe that this closer collaboration will enable us to communicate with you more directly, address your questions faster and participate in your future projects and studies more efficiently.
The Passion of Uniting People...
GEA Pharma Systems, formerly Niro Pharma Systems, unites more than 750 people with a clear pharma engineering passion, providing an advanced one-stop-shop for solid and liquid dosage technology. GEA Pharma Systems is the world leader in advanced solid dose processing for the pharmaceutical industry. We unite the state-of-the-art technologies of Aeromatic, Buck, Collette, Courtoy, Fielder, Lyophil and Niro to combine innovative development and inspired engineering within our entire product range, from individual pieces of equipment to complete process lines.
Innovation
Tomorrow’s technology today
For GEA Pharma Systems, innovation is the key to our success and to continued prosperity for our customers. In fact it’s more than that. We know that by continually stretching the boundaries of what is possible in pharmaceutical processing we have the ability to support our Customers in enhancing the opportunities available to millions of people all over the world. This is what drives our business.
Our innovation takes many forms and affects all parts of the process. We innovate to increase production and reduce costs, to improve containment and safeguard the workforce, to achieve better clinical effectiveness and to enhance quality control. At GEA Pharma Systems the innovation never stops – it’s just part of what we do.
For example we have pioneered Pharma Spray Drying to provide unprecedented control of particle form and release profile for drug development, meeting the most demanding clinical needs. FlexStream™: our new fluid bed coating system offers multiple processing from a single bowl providing both flexibility and cost benefits. MODUL™ and Performa™ tablet presses combine unrivalled containment with fast product change-over and high productivity. The Buck® MC Valve makes the contained handling of active pharmaceutical ingredients much easier and less expensive than has been possible in the past. Consigma™: a unique continuous granulation and drying process that drastically reduces time to market of new medicines and enables the move to a 6-Sigma process; and PharmaConnect™ which enables diverse GEA development equipment to be docked into a single ‘plug and play’ module with full cGMP compliance.
Innovation - not just for its own sake but for improved products, greater safety and enhanced productivity to deliver a better future.